Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 730

    1.

    Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?

    Gungor N, Bacha F, Saad R, Janosky J, Arslanian S.

    Diabetes Care. 2005 Mar;28(3):638-44.PMID: 15735201 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.

    Røder ME, Dinesen B, Hartling SG, Houssa P, Vestergaard H, Sodoyez-Goffaux F, Binder C.

    Diabetes Care. 1999 Apr;22(4):609-14.PMID: 10189540 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance.

    Taha D, Umpaichitra V, Banerji MA, Castells S.

    J Pediatr Endocrinol Metab. 2006 Feb;19(2):135-42.PMID: 16562586 [PubMed - indexed for MEDLINE]Related articles

    4.

    Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.

    Meneilly GS, Elliott T.

    Diabetes Care. 1999 Jan;22(1):112-8.PMID: 10333911 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function.

    Bacha F, Saad R, Gungor N, Arslanian SA.

    Diabetes Care. 2004 Feb;27(2):547-52.PMID: 14747242 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients.

    Tfayli H, Bacha F, Gungor N, Arslanian S.

    Diabetes. 2009 Mar;58(3):738-44. Epub 2008 Dec 10.PMID: 19073767 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    NIDDM in the elderly.

    Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H.

    Diabetes Care. 1996 Dec;19(12):1320-5.PMID: 8941457 [PubMed - indexed for MEDLINE]Related articles

    9.

    Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.

    Anfossi G, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Cavalot F, Trovati M.

    Diabetes Care. 1998 Jan;21(1):121-6.PMID: 9538982 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?

    Bacha F, Saad R, Gungor N, Arslanian SA.

    Diabetes Care. 2006 Jul;29(7):1599-604.PMID: 16801585 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.
    12.

    Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.

    Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV.

    Diabetes Care. 2004 Aug;27(8):2033-40.PMID: 15277436 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Disturbances in beta-cell function in impaired fasting glycemia.

    van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE.

    Diabetes. 2002 Feb;51 Suppl 1:S265-70.PMID: 11815491 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    16.

    Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

    Putz DM, Goldner WS, Bar RS, Haynes WG, Sivitz WI.

    Metabolism. 2004 Nov;53(11):1454-61.PMID: 15536601 [PubMed - indexed for MEDLINE]Related articles

    17.

    In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?

    Burén J, Lindmark S, Renström F, Eriksson JW.

    Metabolism. 2003 Feb;52(2):239-45.PMID: 12601640 [PubMed - indexed for MEDLINE]Related articles

    18.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

    Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

    Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.PMID: 17681171 [PubMed - indexed for MEDLINE]Related articles

    20.

    Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.

    Perseghin G, Ghosh S, Gerow K, Shulman GI.

    Diabetes. 1997 Jun;46(6):1001-9.PMID: 9166672 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data